41-2
41st Parliament,
2nd Session
(October 16, 2013 - August 2, 2015)
Select a different session
Meeting Detail
Friday, June 6, 2014
8:03 AM ET
Location:
Room 256-S, Centre Block
Clerk:
Jessica Richardson
(613) 990-6087
Study on prescription pharmaceuticals in Canada
Topic:
Witnesses
- Amir Attaran, Canadian Research Chair, Population Health and Global Development Policy, University of Ottawa(As an individual)
- Jack Corman, President(Institutional Review Board Services)
- Janet Currie, Representative(Psychiatric Medication Awareness Group)
- Dr. Colin D'Cunha, Director, Global Medical Affairs, Apotex Inc.(Canadian Generic Pharmaceutical Association)
- Perry Eisenschmid, Chief Executive Officer(Canadian Pharmacists Association)
- Michael Gaucher, Director, Pharmaceuticals and Health Workforce Information Services(Canadian Institute for Health Information)
- Matthew Herder, Assistant Professor, Health Law Institute, Faculties of Medicine and Law, Dalhousie University(As an individual)
- Ronald Heslegrave, Executive Director, William Osler Health System(As an individual)
- Dr. David Juurlink, Head, Division of Clinical Pharmacology and Toxicology, Sunnybrook Health Sciences Centre(Institute for Clinical Evaluative Sciences)
- Brian O'Rourke, President and Chief Executive Officer(Canadian Agency for Drugs and Technologies in Health)
- Dr. Robert Peterson, Executive Director, Drug Safety and Effectiveness Network(Canadian Institutes of Health Research)
- Jared Rhines, Vice-president, Scientific and Strategic Affairs(Rx&D)
- Tina Saryeddine, Assistant Vice-President, Research and Policy Analysis(HealthCareCAN (formerly ACAHO-CHA))
- Maureen Smith, Secretary(Canadian Organization for Rare Disorders)
- Mary Wiktorowicz, Chair and Associate Professor, School of Health Policy & Management, Faculty of Health, York University(As an individual)
- Jennifer Zelmer, Executive Vice-President(Canada Health Infoway)
Meeting with interpretation and transcription